The finding that TBX1 regulates stem cell properties through association with miR-200–ZEB2 suggests possible strategies for developing personalized medicine for treating patients with cervical cancer by maintaining a differentiated epithelial cell phenotype. This evidence concerns the gene TBX1 and cervical cancer.